Workflow
Oragenics(OGEN)
icon
Search documents
Oragenics (OGEN) Investor Presentation - Slideshow
2019-10-24 11:19
813 286 7900 ext 232 ajoslyn@oragenics.com Oragenics, Inc. 4902 Eisenhower Blvd., Suite 125 Tampa, FL 33634 www.oragenics.com | --- | --- | --- | --- | --- | --- | |-------|-------|-----------------------|-------|---------------------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Investor Presentation | | NYSE American: OGEN | | Safe Harbor Statement 2 Certain statements made in this presentation include forward-looking actions that Oragenics, Inc. ("Oragenics," or the "Company") an ...
Oragenics(OGEN) - 2019 Q2 - Quarterly Report
2019-08-14 20:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-32188 ORAGENICS, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization ...
Oragenics(OGEN) - 2019 Q1 - Quarterly Report
2019-05-13 20:01
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-32188 ORAGENICS, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organizatio ...
Oragenics(OGEN) - 2018 Q4 - Annual Report
2019-03-29 20:40
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTIONS 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32188 ORAGENICS, INC. (Exact name of registrant as specified in its charter) Florida 59-3410522 (State or Other Jurisdiction of Incorporation or O ...